Vanguard Capital Management
BFRI icon

Vanguard Capital Management’s Biofrontera BFRI Stock Holding History

Vanguard Capital Management’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.5K Buy
71,380
+19,126
+37% +$18.9K ﹤0.01% 3912
2026
Q1 		$42.3K Buy
+52,254
New +$45K ﹤0.01% 3934

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Capital Management's BFRI Position: Q2 2026 in Review

Vanguard Capital Management increased its Biofrontera (BFRI) stake by 37% in Q2 2026, buying an estimated $18.9K and bringing the position to 71,380 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3912.

Vanguard Capital Management first reported a position in BFRI in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • Vanguard Capital Management held 71,380 shares of Biofrontera worth $67.5K as of Q2 2026.
  • Vanguard Capital Management bought 19,126 Biofrontera shares in Q2 2026, an estimated $18.9K.
  • Biofrontera made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3912 holding.
  • Vanguard Capital Management first reported a position in Biofrontera in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.